RENOVORX, INC. Financing Cash Flow
RENOVORX, INC. (RNXT) reported Financing Cash Flow of $9.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- RENOVORX, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $55.00K, a 61.76% increase year-over-year.
- RENOVORX, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $9.05M, a 16.32% decline year-over-year.
- RENOVORX, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- RENOVORX, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- RENOVORX, INC. net cash provided by (used in) financing activities for fiscal 2025 was $10.85M, a 28.26% decline from fiscal 2024.
- RENOVORX, INC. net cash provided by (used in) financing activities for fiscal 2024 was $15.12M, a 201.88% increase from fiscal 2023.
- RENOVORX, INC. net cash provided by (used in) financing activities for fiscal 2023 was $5.01M, a 11823.81% increase from fiscal 2022.
- RENOVORX, INC. net cash provided by (used in) financing activities for fiscal 2022 was $42.00K, a 99.78% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $9.10M 10-Q · filed 2026-08-13 | $9.10M derived: sum of 3 quarters · filed 2026-08-13 | $9.10M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $9.05M 10-Q · filed 2026-05-14 | $9.05M derived: sum of 2 quarters · filed 2026-05-14 | $9.05M derived: sum of 3 quarters · filed 2026-05-14 | $9.08M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $34.00K derived: sum of 3 quarters · filed 2026-08-13 | $10.85M 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $34.00K derived: sum of 2 quarters · filed 2026-08-13 | $10.85M 10-Q · filed 2025-11-13 | $10.88M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $10.85M 10-Q · filed 2026-08-13 | $10.88M derived: sum of 3 quarters · filed 2026-08-13 | $10.89M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $10.81M 10-Q · filed 2026-05-14 | $10.84M derived: sum of 2 quarters · filed 2026-05-14 | $10.86M derived: sum of 3 quarters · filed 2026-05-14 | $20.51M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $48.00K derived: sum of 2 quarters · filed 2026-03-30 | $9.70M derived: sum of 3 quarters · filed 2026-03-30 | $15.12M 10-K · filed 2026-03-30 |
| 2024-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $9.66M derived: sum of 2 quarters · filed 2025-11-13 | $15.09M 10-Q · filed 2025-11-13 | $15.09M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $9.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $15.07M 10-Q · filed 2025-08-14 | $15.07M derived: sum of 3 quarters · filed 2025-08-14 | $15.07M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $5.42M 10-Q · filed 2025-05-15 | $5.42M derived: sum of 2 quarters · filed 2025-05-15 | $5.42M derived: sum of 3 quarters · filed 2025-05-15 | $10.42M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $0.00 derived: sum of 2 quarters · filed 2025-04-01 | $5.00M derived: sum of 3 quarters · filed 2025-04-01 | $5.01M 10-K · filed 2025-04-01 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $5.00M derived: sum of 2 quarters · filed 2024-11-13 | $5.01M 10-Q · filed 2024-11-13 | $5.01M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $5.01M 10-Q · filed 2024-08-13 | $5.01M derived: sum of 3 quarters · filed 2024-08-13 | $5.01M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $6.00K 10-Q · filed 2024-05-10 | $9.00K derived: sum of 2 quarters · filed 2024-05-10 | $13.00K derived: sum of 3 quarters · filed 2024-05-10 | $22.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $7.00K derived: sum of 2 quarters · filed 2024-04-01 | $16.00K derived: sum of 3 quarters · filed 2024-04-01 | $42.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $13.00K derived: sum of 2 quarters · filed 2023-11-13 | $39.00K 10-Q · filed 2023-11-13 | $64.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | $35.00K 10-Q · filed 2023-08-16 | $60.00K derived: sum of 3 quarters · filed 2023-08-16 | $17.35M derived: sum of 4 quarters · filed 2023-08-16 |
| 2022-03-31 | $26.00K 10-Q · filed 2023-05-12 | $51.00K derived: sum of 2 quarters · filed 2023-05-12 | $17.34M derived: sum of 3 quarters · filed 2023-05-12 | $19.32M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $17.31M derived: sum of 2 quarters · filed 2023-03-31 | $19.29M derived: sum of 3 quarters · filed 2023-03-31 | $19.33M 10-K · filed 2023-03-31 |
| 2021-09-30 | $17.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $19.27M derived: sum of 2 quarters · filed 2022-11-14 | $19.30M 10-Q · filed 2022-11-14 | $19.76M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $2.02M 10-Q · filed 2022-08-12 | $2.47M derived: sum of 3 quarters · filed 2022-08-12 | |
| 2021-03-31 | $34.00K 10-Q · filed 2022-05-13 | $487.00K derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $453.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $3.20M 10-K · filed 2022-03-30 | ||
| 2020-09-30 | $2.75M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |